We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease

This study has been terminated.
(Neurogen acquired by Ligand Pharmaceuticals - no further support for study. No safety concerns identified.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00809302
First Posted: December 17, 2008
Last Update Posted: August 28, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Neurogen Corporation
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: October 2009
  Estimated Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)